Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Eun Seo Bae

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1963-5861; OpenAlex author ID A5031990973. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. First author DOI 10.1002/advs.202517849↗
  2. Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue. Co-author DOI 10.1016/j.biopha.2025.118135↗
  3. Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer. Co-author DOI 10.1021/acs.jmedchem.4c00213↗
  4. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Co-author DOI 10.1016/j.biopha.2022.114039↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sang Kook Lee · 4 shared papers, 2023–2026 · strength 0.92
  2. Young Eun Du · 1 shared paper, 2026 · strength 0.23
  3. Dong‐Chan Oh · 1 shared paper, 2026 · strength 0.23
  4. Hyuk‐Jin Cha · 1 shared paper, 2025 · strength 0.23
  5. Yoon-Ze Shin · 1 shared paper, 2025 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.